A case control study:The role of leukotriene receptor antagonist in cardiovascular risk

Conclusions: The results do not show a reduction of the MI risk in patients using a LTRA; situation somehow different in IS patients from primary health care centers with a slightly protective effect of montelukast in reducing the IS risk, that, however, did not reach statistical significance. Future studies should require a larger sample size and monitor asthmatic patients from primary care.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Airway Pharmacology and Treatment Source Type: research